Filing Flows › Comparisons › CVS vs GRDN
CVS Health vs Guardian Pharmacy Services: CVS and GRDN compared
CVS Health is the larger company: $108.4B of revenue in its latest quarter (Q3 2026) against $371M for Guardian Pharmacy Services (Q3 2026). CVS Health is growing faster (+5% against -2% a year earlier). Guardian Pharmacy Services is more profitable, with an operating margin of 6.8% against 3.3%.
Where the money goes: CVS and GRDN
CVS Health (CVS) · Q3 2026
CVS Health, Q3 2026: revenue $108.4B (+5% year over year), operating margin 3.3%, net earnings $2.2B, operating cash flow $4.7B. The chart follows the revenue to costs, profit and cash.
Guardian Pharmacy Services (GRDN) · Q3 2026
Guardian Pharmacy Services, Q3 2026: revenue $371M (-2% year over year), operating margin 6.8%, net earnings $18.7M, operating cash flow $43.4M. The chart follows the revenue to costs, profit and cash.
| CVS Health (CVS) | Guardian Pharmacy Services (GRDN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $108.4B | $371M |
| Revenue growth, Y/Y | +5% | -2% |
| Gross margin | — | 23.0% |
| Operating margin | 3.3% | 6.8% |
| Net earnings | $2.2B | $18.7M |
| Net margin | 2.0% | 5.0% |
| Operating cash flow | $4.7B | $43.4M |
| Free cash flow | $3.9B | $39.3M |
| Market value | $105.0B | $2.7B |
| P/E | 9.5× | 35.6× |
| Analysts’ mean target | $113.76 | $49.86 |
Questions
Which is bigger, CVS Health or Guardian Pharmacy Services?
CVS Health is the larger company: $108.4B of revenue in its latest quarter (Q3 2026) against $371M for Guardian Pharmacy Services (Q3 2026).
Is CVS Health or Guardian Pharmacy Services growing faster?
CVS Health is growing faster (+5% against -2% a year earlier).
Which is more profitable, CVS Health or Guardian Pharmacy Services?
Guardian Pharmacy Services is more profitable, with an operating margin of 6.8% against 3.3%.
More: CVS Health earnings · how CVS Health makes money · Guardian Pharmacy Services earnings · how Guardian Pharmacy Services makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.